Economic benefit to society at large of total knee arthroplasty in younger patients a markov analysis

Journal of Bone and Joint Surgery

Volumn 96, Issue 2, 2014, Pages 119-126

  Bedair, Hany ^a   Cha, Thomas D ^a   Hansen, Viktor J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AVERAGE; CASE REPORT; CONSERVATIVE TREATMENT; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INCOME; KNEE OSTEOARTHRITIS; MARKOV MODEL; MIDDLE AGED; MODEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; REVIEW; SENSITIVITY ANALYSIS; SOCIETY; TOTAL KNEE REPLACEMENT; ARTICLE; ECONOMICS; KNEE ARTHROPLASTY; METHODOLOGY; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; TIME; UNITED STATES;

ADULT; ARTHROPLASTY, REPLACEMENT, KNEE; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; MARKOV CHAINS; MIDDLE AGED; MODELS, ECONOMIC; OSTEOARTHRITIS, KNEE; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; UNITED STATES;

EID: 84896288287     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.01736     Document Type: Review

References (59)

1. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-Articular hyaluronic acid in treatment of knee osteoarthritis: A meta-Analysis. JAMA. 2003 Dec 17;290(23): 3115-21.
2. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal antiinflammatory drugs in the treatment of osteoarthritis: meta-Analysis of randomised controlled trials. BMJ. 2004 Aug 7;329(7461): 324. Epub 2004 Jul 30.
3. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mǔllner M. Intra-Articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-Analysis. CMAJ. 2005 Apr 12;172(8): 1039-43.
4. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006 Apr 19;(2): CD005328.
5. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8): 795-808.
6. Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006 Jan 25;(1): CD004257.
7. Reichenbach S, Sterchi R, SchererM, Trelle S, Bǔrgi E, Bǔrgi U, Dieppe PA, Jǔni P. Meta-Analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007 Apr 17;146(8): 580-90.
8. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007 Jul;56(7): 2267-77.
9. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008 Feb;16(2): 137-62.
10. Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, Zack MM, Nyŕen O. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med. 2001 Dec 20;345(25): 1801-8.
11. Garcia Rodríguez LA, Herńandez-Díaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res. 2001;3(2): 98-101. Epub 2000 Dec 15.
12. Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following tricompartmental total knee replacement. A meta-Analysis. JAMA. 1994 May 4;271(17): 1349-57.
13. Ethgen O, Bruyére O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004 May;86-A(5): 963-74.
14. Hartley RC, Barton-Hanson NG, Finley R, Parkinson RW. Early patient outcomes after primary and revision total knee arthroplasty. A prospective study. J Bone Joint Surg Br. 2002 Sep;84(7): 994-9.
15. Kane RL, Saleh KJ,Wilt TJ, Bershadsky B. The functional outcomes of total knee arthroplasty. J Bone Joint Surg Am. 2005 Aug;87(8): 1719-24.
16. Rodriguez JA, Bhende H, Ranawat CS. Total condylar knee replacement: A 20-year followup study. Clin Orthop Relat Res. 2001 Jul;(388): 10-7.
17. Harris WH, Sledge CB. Total hip and total knee replacement (2). N Engl J Med. 1990 Sep 20;323(12): 801-7.
18. Gill GS, Joshi AB, Mills DM. Total condylar knee arthroplasty. 16-To 21-year results. Clin Orthop Relat Res. 1999 Oct;(367): 210-5.
19. Duffy GP, Trousdale RT, Stuart MJ. Total knee arthroplasty in patients 55 years old or younger. 10-To 17-year results. Clin Orthop Relat Res. 1998 Nov;(356): 22-7.
20. Lavernia CJ, Guzman JF, Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res. 1997 Dec;(345): 134-9.
21. Burns AW, Bourne RB, Chesworth BM, MacDonald SJ, Rorabeck CH. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res. 2006 May;446: 29-33.
22. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009 Jun 22;169(12): 1113-21; discussion 1121-2.
23. Jenkins PJ, Clement ND, Hamilton DF, Gaston P, Patton JT, Howie CR. Predicting the cost-effectiveness of total hip and knee replacement: A health economic analysis. Bone Joint J. 2013 Jan;95-B(1): 115-21.
24. Burbine SA, Weinstein AM, Reichmann WM, Rome BN, Collins JE, Katz JN, Losina E. Projecting the future public health impact of the trend toward earlier onset of knee osteoarthritis in the past 20 years. In: Proceedings of the American College of Rheumatology (ACR) Annual Scientific Meeting; 2011 Nov 4-9. Chicago, IL.
25. DeNavas-Walt C, Proctor BD, Smith JC. Income, poverty, and health insurance coverage in the United States: 2010. U.S. Census Bureau, Current Population Reports; 2011. http://www.census.gov/prod/2011pubs/p60-239.pdf. Accessed 2013 Aug 28.
26. Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum. 2005 Oct 15;53(5): 673-81.
27. Li X, Gignac MA, Anis AH. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care. 2006 Apr;44(4): 304-10.
28. Centers for Disease Control and Prevention. United States Life Tables, 2008. http://www.cdc.gov/nchs/products/life-Tables.htm. Accessed 2013 Aug 28.
29. U.S. Bureau of Labor Statistics. Consumer price index detailed report: data for October 2012. 2012. http://www.bls.gov/cpi/cpid1210.pdf. Accessed 2013 Aug 28.
30. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996 Oct 16;276(15): 1253-8.
31. Australian Orthopaedic Association. Hip and knee arthroplasty: Annual report. 2012. https://aoanjrr.dmac.adelaide.edu.au/documents/10180/60142/ Annual%20-Report%202012?version=1.2&t=1355186837517. Accessed 2013 Aug 28.
32. Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, Fang F, Schwartz TA, Abbate LM, Callahan LF, Kalsbeek WD, Hochberg MC. Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: The Johnston County Osteoarthritis Project. J Rheumatol. 2007 Jan;34(1): 172-80.
33. U.S. Census Bureau. Annual estimates of the population by five-year age groups and sex for the united states: April 1, 2000 to July 1, 2006. 2006. http://www. census.gov/popest/data/national/asrh/2006/tables/NC-EST2006-01.xls. Accessed 2013 Aug 28.
34. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009 Oct;467(10): 2606-12. Epub 2009 Apr 10.
35. Weinstein AM, Rome BN, Reichmann WM, Collins JE, Burbine SA, Thornhill TS, Wright J, Katz JN, Losina E. Estimating the burden of total knee replacement in the United States. J Bone Joint Surg Am. 2013 Mar 6;95(5): 385-92.
36. Lombardi AV Jr, Nunley RM, Berend KR, Ruh EL, Clohisy JC, Hamilton WG, Della Valle CJ, Parvizi J, Barrack RL. Do Patients Return to Work After Total Knee Arthroplasty? Clin Orthop Relat Res. 2013 Jun 13. [Epub ahead of print]
37. London NJ, Miller LE, Block JE. Clinical and economic consequences of the treatment gap in knee osteoarthritis management. Med Hypotheses. 2011 Jun;76(6): 887-92. Epub 2011 Mar 25.
38. Styron JF, Barsoum WK, Smyth KA, Singer ME. Preoperative predictors of returning to work following primary total knee arthroplasty. J Bone Joint Surg Am. 2011 Jan 5;93(1): 2-10.
39. Lyall H, Ireland J, El-Zebdeh MY. The effect of total knee replacement on employment in patients under 60 years of age. Ann R Coll Surg Engl. 2009 Jul;91(5): 410-3. Epub 2009 Apr 02.
40. Palmer KT. The older worker with osteoarthritis of the knee. Br Med Bull. 2012 Jun;102: 79-88. Epub 2012 Apr 26.
41. Kuijer PP, de Beer MJ, Houdijk JH, Frings-Dresen MH. Beneficial and limiting factors affecting return to work after total knee and hip arthroplasty: A systematic review. J Occup Rehabil. 2009 Dec;19(4): 375-81. Epub 2009 Aug 20.
42. U.S. Bureau of Labor Statistics. Schumann R. Work schedules in the national compensation survey. 2008. http://www.bls.gov/opub/cwc/ cm20080722ar01p1. htm. Accessed 2013 Aug 28.
43. Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC. The economic burden of disabling hip and knee osteoarthritis (OA) fromthe perspective of individuals living with this condition. Rheumatology (Oxford). 2005 Dec;44(12): 1531-7. Epub 2005 Aug 9.
44. Yelin E, Murphy L, Cisternas MG, Foreman AJ, Pasta DJ, Helmick CG. Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheum. 2007 May;56(5): 1397-407.
45. Berger A, Bozic K, Stacey B, Edelsberg J, Sadosky A, Oster G. Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum. 2011 Aug;63(8): 2268-75.
46. Bozic KJ, Stacey B, Berger A, Sadosky A, Oster G. Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res. 2012 Mar 23;12: 73.
47. Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: A retrospective claims database analysis. J Med Econ. 2011;14(4): 497-507. Epub 2011 Jun 20.
48. Maradit Kremers H, Visscher SL, Moriarty JP, Reinalda MS, Kremers WK, Naessens JM, Lewallen DG. Determinants of direct medical costs in primary and revision total knee arthroplasty. Clin Orthop Relat Res. 2013 Jan;471(1): 206-14.
49. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009 Jan;91(1): 128-33.
50. BrandesM, Ringling M,Winter C, Hillmann A, Rosenbaum D. Changes in physical activity and health-related quality of life during the first year after total knee arthroplasty. Arthritis Care Res (Hoboken). 2011 Mar;63(3): 328-34. Epub 2010 Oct 27.
51. Dahm DL, Barnes SA, Harrington JR, Berry DJ. Patient reported activity after revision total knee arthroplasty. J Arthroplasty. 2007 Sep;22(6 Suppl 2): 106-10.
52. Dahm DL, Barnes SA, Harrington JR, Sayeed SA, Berry DJ. Patient-reported activity level after total knee arthroplasty. J Arthroplasty. 2008 Apr;23(3): 401-7.
53. Lovald ST, Lau E, Ong K, Kurtz SM, Schmier JK, Parvizi J, Bozic KJ. Cost and disease outcomes of total knee arthroplasty patients in the Medicare population. Presented as a poster exhibit at the American Academy of Orthopaedic Surgeons Annual Meeting; 2012 Feb 7-11; San Francisco, CA. Poster no. 149.
54. Berger A, Hartrick C, Edelsberg J, Sadosky A, Oster G. Direct and indirect economic costs among private-sector employees with osteoarthritis. J Occup Environ Med. 2011 Nov;53(11): 1228-35.
55. Dibonaventura MD, Gupta S, McDonald M, Sadosky A, Pettitt D, Silverman S. Impact of self-related osteoarthritis severity in an employed population: crosssectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes. 2012 Mar 15;10: 30.
56. Scott WNN, Bryce CD, Long WJ, Benner RW, Hollenebeak CS, Scuderi GR, Cushner FD. Long term (35 years) outcome analysis of the young total knee patient: minimum 20 years. Read at the Annual Meeting of American Academy of Orthopaedic Surgeons; 2013 Mar 19-23; Chicago, IL. Paper no. 359.
57. Fehring TK, Odum SM, Troyer JL, Iorio R, Kurtz SM, Lau EC. Joint replacement access in 2016: A supply side crisis. J Arthroplasty. 2010 Dec;25(8): 1175-81. Epub 2010 Sep 25.
58. Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am. 2004 Sep;86-A(9): 1909-16.
59. Manley M, Ong K, Lau E, Kurtz SM. Total knee arthroplasty survivorship in the United States Medicare population: effect of hospital and surgeon procedure volume. J Arthroplasty. 2009 Oct;24(7): 1061-7. Epub 2008 Nov 1.